Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

INTRODUCTION: The sequence of chemotherapy and pembrolizumab may affect antitumor immune response and efficacy of immunotherapy. METHODS: This multicenter, randomized, phase 2 trial was designed to evaluate the efficacy of two sequences of chemotherapy and pembrolizumab in patients with stage 4 NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Hensing, Thomas A., Wang, Xiaofei, Stinchcombe, Thomas E., Gao, Junheng, Knopp, Michael V., Watson, Mark, Dudek, Arkadiusz Z., Graziano, Stephen L., Patel, Jyoti D., Faller, Bryan A., Dragnev, Konstantin H., Kozono, David, Vokes, Everett E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474361/
https://www.ncbi.nlm.nih.gov/pubmed/34590049
http://dx.doi.org/10.1016/j.jtocrr.2021.100208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474361/
https://www.ncbi.nlm.nih.gov/pubmed/34590049
http://dx.doi.org/10.1016/j.jtocrr.2021.100208

Ejemplares similares